Xiaobin Wu
Known title: President, COO & GM ChinaCIK: 0001739452
Associated companies
Transaction History
| ONC | ▼ Sell | Open Market | 280 | $106K | 8/25/2026 | View on chart |
| ONC | ▼ Sell | Open Market | 1,292 | $357K | 6/23/2026 | View on chart |
| ONC | ▼ Sell | Open Market | 1,357 | $362K | 6/16/2026 | View on chart |
| ONC | ▲ Buy | Grant | 118,625 | $0 | 6/11/2026 | View on chart |
| ONC | ▼ Sell | Open Market | 626 | $164K | 6/11/2026 | View on chart |
| ONC | ▼ Sell | Open Market | 1,444 | $389K | 6/8/2026 | View on chart |
| ONC | ▼ Sell | Open Market | 40 | $11K | 6/8/2026 | View on chart |
| ONC | ▲ Buy | Grant | 168,922 | $0 | 3/6/2026 | View on chart |
| ONC | ▲ Buy | Grant | 78,624 | $0 | 3/6/2026 | View on chart |
| ONC | ▼ Sell | Open Market | 3,155 | $1.2M | 11/17/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 826 | $315K | 11/17/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 10 | $4K | 11/17/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 1,769 | $674K | 11/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 4,240 | $1.6M | 11/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 500 | $175K | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 3,240 | $1.1M | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 251 | $89K | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $36K | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 154 | $56K | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 4,846 | $1.7M | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 789 | $278K | 11/12/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 120 | $43K | 11/12/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 30,756 | $4.8M | 8/14/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 9,180 | $1.5M | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 400 | $120K | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 5,800 | $1.8M | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 6,965 | $2.1M | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 500 | $152K | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 8,522 | $2.6M | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 12,232 | $3.7M | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 4,917 | $1.5M | 8/14/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 600 | $185K | 8/14/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 22,773 | $4.0M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 8,900 | $2.7M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 5,800 | $1.8M | 8/13/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 27,085 | $4.2M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 3,517 | $1.1M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 4,500 | $1.4M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 7,359 | $2.2M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 9,637 | $3.0M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 528 | $161K | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 9,617 | $3.0M | 8/13/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 1,363 | $354K | 6/23/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 630 | $158K | 6/17/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 1,443 | $383K | 6/16/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $27K | 6/16/2025 | View on chart |
| ONC | ▲ Buy | Grant | 123,370 | $0 | 6/10/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 400 | $102K | 6/6/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 234 | $60K | 6/6/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 400 | $100K | 6/6/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 400 | $101K | 6/6/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 500 | $126K | 6/6/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 16,477 | $2.0M | 4/1/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 35,444 | $6.2M | 4/1/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 28,253 | $7.9M | 4/1/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 6,364 | $1.8M | 4/1/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 12,221 | $3.5M | 4/1/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 5,083 | $1.4M | 4/1/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 0 | $0 | 3/14/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 7,048 | $1.2M | 3/5/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 44,873 | $5.4M | 3/5/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 200 | $53K | 3/5/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 11,360 | $3.0M | 3/5/2025 | View on chart |
| ONC | ▲ Buy | Grant | 103,883 | $0 | 3/5/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 22,537 | $5.9M | 3/5/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 17,824 | $4.6M | 3/5/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 0 | $0 | 2/28/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 21,267 | $3.6M | 2/20/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 21,267 | $5.1M | 2/20/2025 | View on chart |
| ONC | ▲ Buy | Option Exercise | 30,654 | $5.2M | 2/18/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 19,576 | $4.7M | 2/18/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 7,919 | $1.9M | 2/18/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 3,159 | $765K | 2/18/2025 | View on chart |
| ONC | ▼ Sell | Open Market | 0 | $0 | 12/6/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 4,500 | $901K | 9/19/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 500 | $100K | 9/17/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 700 | $134K | 9/3/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 274 | $53K | 9/3/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 275 | $52K | 9/3/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 2,032 | $382K | 9/3/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 2,275 | $433K | 9/3/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 23 | $4K | 6/24/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 400 | $64K | 6/24/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 1,036 | $165K | 6/24/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $47K | 6/18/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 1,121 | $172K | 6/18/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 906 | $140K | 6/18/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $47K | 6/18/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 627 | $100K | 6/17/2024 | View on chart |
| ONC | ▲ Buy | Grant | 253,409 | $0 | 6/5/2024 | View on chart |
| ONC | ▼ Sell | Open Market | 1,495 | $273K | 6/26/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 1,753 | $337K | 6/20/2023 | View on chart |
| ONC | ▲ Buy | Grant | 200,447 | $0 | 6/15/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 531 | $119K | 6/7/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 1,147 | $257K | 6/7/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 789 | $178K | 6/7/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 824 | $186K | 6/7/2023 | View on chart |
| ONC | ▼ Sell | Open Market | 7,000 | $1.8M | 5/8/2023 | View on chart |
| ONC | ▲ Buy | Grant | 187,876 | $0 | 6/22/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 1,010 | $146K | 6/21/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 578 | $81K | 6/17/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 3,410 | $484K | 6/6/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 800 | $129K | 5/5/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 500 | $85K | 5/5/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $17K | 5/5/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 3,350 | $547K | 5/5/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 175 | $29K | 5/5/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 1,100 | $182K | 5/5/2022 | View on chart |
| ONC | ▼ Sell | Open Market | 700 | $117K | 5/5/2022 | View on chart |
| ONC | ▲ Buy | Grant | 0 | $0 | 12/15/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $108K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 449 | $163K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $37K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 485 | $177K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $110K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 200 | $73K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 200 | $74K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 200 | $75K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $38K | 11/9/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $103K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $104K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $104K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 449 | $157K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 164 | $57K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 200 | $72K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 4,433 | $1.6M | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $105K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $35K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $106K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 300 | $107K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 420 | $146K | 11/8/2021 | View on chart |
| ONC | ▼ Sell | Open Market | 100 | $36K | 11/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BeOne Medicines Receives Rating Upgrade and Added to Top-Rated List
BeOne Medicines Ltd. has been upgraded to a top rating by analysts. It was also added to a list of top-rated stocks for the week. The upgrade follows recent earnings and infrastructure updates discussed in a broader market analysis. The move may influence investor perception of the company.
BeOne Medicines Receives Rating Upgrade and Added to Top-Rated List. BeOne Medicines Ltd. has been upgraded to a top rating by analysts. It was also added to a list of top-rated stocks for the week. The upgrade follows recent earnings and infrastructure updates discussed in a broader market analysis. The move may influence investor perception of the company.